(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
Live Chart Being Loaded With Signals
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments...
Stats | |
---|---|
आज की मात्रा | 109.00 |
औसत मात्रा | 190.00 |
बाजार मूल्य | 5.55B |
Last Dividend | $0.184 ( 2023-09-21 ) |
Next Dividend | $0 ( N/A ) |
P/E | 21.53 |
ATR14 | $0 (0.00%) |
Aspen Pharmacare Holdings सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Aspen Pharmacare Holdings वित्तीय
Annual | 2023 |
राजस्व: | $2.29B |
सकल लाभ: | $1.02B (44.59 %) |
EPS: | $0.660 |
FY | 2023 |
राजस्व: | $2.29B |
सकल लाभ: | $1.02B (44.59 %) |
EPS: | $0.660 |
FY | 2022 |
राजस्व: | $2.54B |
सकल लाभ: | $1.15B (45.40 %) |
EPS: | $0.940 |
FY | 2021 |
राजस्व: | $37.77B |
सकल लाभ: | $17.76B (47.03 %) |
EPS: | $10.53 |
Financial Reports:
No articles found.
Aspen Pharmacare Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.133 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.184 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.101 | 2010-10-06 |
Last Dividend | $0.184 | 2023-09-21 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-11 | |
Next Payout Date | N/A | |
# dividends | 12 | -- |
Total Paid Out | $2.03 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.69 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.17 | |
Div. Directional Score | 7.90 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TELNY | Ex Dividend Knight | 2023-10-19 | Semi-Annually | 0 | 0.00% | |
HNFSA | Ex Dividend Junior | 2023-08-09 | Quarterly | 0 | 0.00% | |
ARKAY | Ex Dividend Junior | 2023-05-11 | Annually | 0 | 0.00% | |
PCLB | Ex Dividend Knight | 2023-09-01 | Quarterly | 0 | 0.00% | |
DIMC | Ex Dividend Knight | 2023-09-28 | Quarterly | 0 | 0.00% | |
UEPCO | Ex Dividend Knight | 2023-07-20 | Quarterly | 0 | 0.00% | |
JMPLY | Ex Dividend Knight | 2023-06-15 | Semi-Annually | 0 | 0.00% | |
BKHYY | Ex Dividend Junior | 2023-08-25 | Annually | 0 | 0.00% | |
RMYHY | Ex Dividend Junior | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
EVSBY | Ex Dividend Knight | 2023-05-24 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.114 | 1.500 | 7.72 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0349 | 1.200 | 8.84 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0743 | 1.500 | -0.285 | -0.428 | [0.1 - 1] |
payoutRatioTTM | 0.315 | -1.000 | 6.85 | -6.85 | [0 - 1] |
currentRatioTTM | 1.918 | 0.800 | 5.41 | 4.33 | [1 - 3] |
quickRatioTTM | 1.053 | 0.800 | 8.51 | 6.81 | [0.8 - 2.5] |
cashRatioTTM | 0.505 | 1.500 | 8.30 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.259 | -1.500 | 5.68 | -8.52 | [0 - 0.6] |
interestCoverageTTM | 88.18 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 14.11 | 2.00 | 5.30 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 7.62 | 2.00 | 6.19 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.422 | -1.500 | 8.31 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.450 | 1.000 | 5.83 | 5.83 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.200 | 1.000 | 8.00 | 8.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.174 | 1.000 | -0.146 | -0.146 | [0.2 - 2] |
assetTurnoverTTM | 0.307 | 0.800 | -1.290 | -1.032 | [0.5 - 2] |
Total Score | 10.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 21.09 | 1.000 | 7.97 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0743 | 2.50 | -0.183 | -0.428 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 7.62 | 2.00 | 7.46 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.00419 | 1.500 | 9.90 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 14.11 | 2.00 | 5.30 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.315 | 1.500 | 6.85 | -6.85 | [0 - 1] |
pegRatioTTM | 0.0356 | 1.500 | -3.10 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.147 | 1.000 | 8.83 | 0 | [0.1 - 0.5] |
Total Score | 5.17 |
Aspen Pharmacare Holdings
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं